Clinical effect of combined use of shouhu-san and mequitazine in recurrent vaginal candidiasis received protracted antibiotic therapy
Chimura, T.; Funayama, T.
Japanese Journal of Antibiotics 47(5): 553-560
1994
ISSN/ISBN: 0368-2781 PMID: 8051796 Document Number: 433550
Clinical effects of combined use of Shouhu-san and mequitazine in 8 cases with recurrent vaginal candidiasis in obstetrics and gynecology were studied, and the following results were obtained. Shouhu-san was orally administered to 8 patients, with recurrent vaginal candidiasis, using a daily dose of 7.5 g. The duration of treatment was between 14 to 28 days. Also mequitazine was used in combination, with a daily dose of 6 mg. The clinical responses were good in all 8 and the efficacy rate was 100%. The microbiological eradication was obtained in all 8 cases of Candida albicans. Neither subjective nor objective side effects were observed. These results suggest that a combination of Shouhu-san and mequitazine appears to be useful of immunologic aspects against recurrent vaginal candidiasis.